Isis will provide Biogazelle with access to its antisense platform for the large-scale validation of therapeutic lncRNA targets from Biogazelle's target identification pipeline.
The accreditation is for the Belgian firm's mRNA, miRNA, and long non-coding RNA expression services.
NEW YORK (GenomeWeb) — Biogazelle said today that it has received a €2 million ($2.5 million) investment from Qbic Arkiv Fund, Foundation Majoie, and SOFI (Spin-Off Financing Instrument).
Core Life Sciences has signed a deal with Biogazelle that lets that company distribute qbase+, Core's software for analyzing qPCR data, in California.
Core Life Sciences said today that it has partnered with Belgium's Biogazelle to distribute its qbase+ qPCR software in California.
NEW YORK (GenomeWeb News) – Core Life Sciences announced this week that it and Biogazelle have reached an agreement to distribute Biogazelle's qbase+ software in California.
Belgium's Flanders Institute for Biotechnology, VIB, has licensed Biogazelle’s qbase+ software to support its real time PCR-based research projects.
BITS, the bioinformatics training and service facility of Belgium's Vlaams Instituut voor Biotechnologie, or VIB, will use Biogazelle's qbase+ software for PCR analysis, Biogazelle said this week.
Bio-Rad this week introduced qPCR assays and panels that have been wet-lab validated to meet the minimum information for publication of quantitative real-time PCR experiments, or MIQE, guidelines.
Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.
Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.
Vox explores a proposal to institute a lottery system to award grant funds.
In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.